SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,529.07 -242.65
( -0.33%)

Global Indices

Nasdaq

51,369.65 -132.86
(-0.26%)

Dow Jones

7,690.99 -13.70
(-0.18%)

Hang Seng

65,155.57 -722.05
(-1.10%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.79 -0.10
(-0.10%)

EUR-INR

109.09 0.01
(0.01%)

GBP-INR

126.83 0.01
(0.01%)

JPY-INR

0.61 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Graphisads Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

91904

INE0POU01017

47.6348316

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GRAPHISAD

17.89

46.42

EPS(TTM)

Face Value()

Div & Yield %

1.42

Back

Fredun Pharmaceuticals consolidated net profit rises 93.94% in the June 2026 quarter

Aug 05,2026

Net profit of Fredun Pharmaceuticals rose 93.94% to Rs 13.13 crore in the quarter ended June 2026 as against Rs 6.77 crore during the previous quarter ended June 2025. Sales rose 90.75% to Rs 227.76 crore in the quarter ended June 2026 as against Rs 119.40 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	227.76	119.40	91
OPM %	14.37	14.23	-
PBDT	24.12	10.46	131
PBT	20.55	9.04	127
NP	13.13	6.77	94

72,529.07 -242.65 ( -0.33%)

51,369.65 -132.86 (-0.26%)

7,690.99 -13.70 (-0.18%)

65,155.57 -722.05 (-1.10%)

10,628.22 -56.66 (-0.53%)

95.79 -0.10 (-0.10%)

109.09 0.01 (0.01%)

126.83 0.01 (0.01%)

0.61 0.00 (0.68%)